Syndax Pharmaceuticals, Inc. (SNDX) NASDAQ
$17.99 (0.33) (-1.80%)
Market Cap: $1.53B
As of 09/12/24 04:00 PM EDT. Market closed.
Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ
$17.99
(0.33) (-1.80%)
Market Cap: $1.53B
As of 09/12/24 04:00 PM EDT. Market closed.
Add to Portfolio
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Michael A. Metzger M.B.A.
Full Time Employees
184
CEO Compensation (Base)
$678,400
CEO Compensation (Total)
$9.13M
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Michael A. Metzger M.B.A.
Full Time Employees
184
CEO Compensation (Base)
$678,400
CEO Compensation (Total)
$9.13M
URL
Address
35 Gatehouse Drive, 35 Gatehouse Dr Fl 3, MA, Waltham, 02451.
PRICE CHART FOR SYNDAX PHARMACEUTICALS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$18.48
Previous Close
$18.32
Days Range
$17.95 - $18.59
52 week range
$11.22 - $25.34
Volume
766,074
Avg. Volume (30 days)
1,048,908
Market Cap
$1.53B
Dividend Yield
-
P/E
(5.29)
Shares Outstanding
85,096,400
Open
$18.48
Previous Close
$18.32
Days Range
$17.95 - $18.59
52 week range
$11.22 - $25.34
Volume
766,074
Avg. Volume (30 days)
1,048,908
Market Cap
$1.53B
Dividend Yield
-
P/E
(5.29)
Shares Outstanding
85,096,400
FINANCIAL STATEMENTS FOR SYNDAX PHARMACEUTICALS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SYNDAX PHARMACEUTICALS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Goldan Keith A. | Chief Financial Officer | Jun 14, 2024 | Buy | $20.03 | 1,250 | 25,037 | 52,623 | Jun 17, 2024, 09:26 AM |
| Goldan Keith A. | Chief Financial Officer | Jan 31, 2024 | Option Exercise | $17.42 | 1,183 | 20,608 | 4,673 | Feb 09, 2024, 04:05 PM |
| Goldan Keith A. | Chief Financial Officer | Jul 31, 2023 | Option Exercise | $18.12 | 862 | 15,619 | 3,490 | Feb 09, 2024, 04:05 PM |
| Morrison Briggs | Director | Aug 09, 2023 | Option Exercise | $8.77 | 52,855 | 463,538 | 70,691 | Aug 10, 2023, 06:50 AM |
| Morrison Briggs | Director | Aug 09, 2023 | Sale | $18.27 | 52,855 | 965,402 | 17,836 | Aug 10, 2023, 06:50 AM |
| Meury William | Director | Aug 02, 2023 | Option Exercise | $8.02 | 83,000 | 665,250 | 83,000 | Aug 03, 2023, 09:12 AM |
| Meury William | Director | Aug 02, 2023 | Sale | $20.46 | 83,000 | 1,697,810 | 48,000 | Aug 03, 2023, 09:12 AM |
| Morrison Briggs | Director | Jul 10, 2023 | Option Exercise | $8.77 | 52,855 | 463,538 | 70,691 | Jul 11, 2023, 09:23 AM |
| Morrison Briggs | Director | Jul 10, 2023 | Sale | $20.40 | 52,855 | 1,078,068 | 17,836 | Jul 11, 2023, 09:23 AM |
| Goldan Keith A. | Chief Financial Officer | Jun 13, 2023 | Sale | $22.31 | 577 | 12,873 | 2,628 | Jun 14, 2023, 04:20 PM |
| Morrison Briggs | Director | Jun 09, 2023 | Option Exercise | $7.66 | 52,855 | 404,787 | 70,691 | Jun 09, 2023, 05:32 PM |
| Morrison Briggs | Director | Jun 09, 2023 | Sale | $21.18 | 52,855 | 1,119,421 | 46,109 | Jun 09, 2023, 05:32 PM |
| Morrison Briggs | Director | May 09, 2023 | Option Exercise | $6.38 | 52,855 | 337,215 | 70,691 | May 10, 2023, 04:11 PM |
| Morrison Briggs | Director | May 09, 2023 | Sale | $21.41 | 52,855 | 1,131,478 | 17,836 | May 10, 2023, 04:11 PM |
| Morrison Briggs | Director | Apr 10, 2023 | Option Exercise | $6.38 | 52,855 | 337,215 | 70,691 | Apr 12, 2023, 04:03 PM |
| Morrison Briggs | Director | Apr 10, 2023 | Sale | $19.53 | 52,855 | 1,032,237 | 17,836 | Apr 12, 2023, 04:03 PM |
| Morrison Briggs | President, Head of R&D | Mar 13, 2023 | Option Exercise | $6.38 | 52,854 | 337,209 | 70,690 | Mar 14, 2023, 04:42 PM |
| Morrison Briggs | President, Head of R&D | Mar 13, 2023 | Sale | $22.53 | 52,854 | 1,190,674 | 17,836 | Mar 14, 2023, 04:42 PM |
| Ordentlich Peter | Chief Scientific Officer | Feb 15, 2023 | Option Exercise | $6.95 | 25,000 | 173,791 | 17,428 | Feb 17, 2023, 06:09 PM |
| Ordentlich Peter | Chief Scientific Officer | Feb 15, 2023 | Sale | $25.84 | 25,000 | 646,093 | 0 | Feb 17, 2023, 06:09 PM |
| Metzger Michael A | Chief Executive Officer | Feb 06, 2023 | Option Exercise | $6.38 | 5,959 | 38,018 | 23,618 | Feb 08, 2023, 04:49 PM |
| Metzger Michael A | Chief Executive Officer | Feb 06, 2023 | Sale | $27.64 | 5,959 | 164,697 | 17,659 | Feb 08, 2023, 04:49 PM |
| Morrison Briggs | President, Head of R&D | Feb 06, 2023 | Option Exercise | $6.38 | 52,854 | 337,209 | 70,690 | Feb 08, 2023, 04:49 PM |
| Morrison Briggs | President, Head of R&D | Feb 06, 2023 | Sale | $26.83 | 52,854 | 1,417,909 | 17,836 | Feb 08, 2023, 04:49 PM |
| Ordentlich Peter | Chief Scientific Officer | Jan 31, 2023 | Option Exercise | $17.32 | 69 | 1,195 | 69 | Feb 03, 2023, 04:59 PM |
| Ordentlich Peter | Chief Scientific Officer | Feb 01, 2023 | Sale | $28.43 | 69 | 1,962 | 0 | Feb 03, 2023, 04:59 PM |
| Legault Pierre | Director | Jan 12, 2023 | Option Exercise | $9.47 | 24,000 | 227,280 | 56,000 | Jan 13, 2023, 04:44 PM |
| Legault Pierre | Director | Jan 13, 2023 | Option Exercise | $13.58 | 15,000 | 203,700 | 42,000 | Jan 13, 2023, 04:44 PM |
| Legault Pierre | Director | Jan 12, 2023 | Sale | $26.74 | 24,000 | 641,782 | 32,000 | Jan 13, 2023, 04:44 PM |
| Legault Pierre | Director | Jan 13, 2023 | Sale | $27.00 | 15,000 | 405,000 | 32,000 | Jan 13, 2023, 04:44 PM |
| Ordentlich Peter | Chief Scientific Officer | Dec 02, 2022 | Option Exercise | $6.38 | 17,200 | 109,736 | 17,465 | Dec 02, 2022, 05:01 PM |
| Ordentlich Peter | Chief Scientific Officer | Dec 01, 2022 | Option Exercise | $6.37 | 7,800 | 49,651 | 4,293 | Dec 02, 2022, 05:01 PM |
| Ordentlich Peter | Chief Scientific Officer | Dec 02, 2022 | Sale | $25.05 | 17,200 | 430,936 | 265 | Dec 02, 2022, 05:01 PM |
| Ordentlich Peter | Chief Scientific Officer | Dec 01, 2022 | Sale | $25.01 | 7,800 | 195,089 | 265 | Dec 02, 2022, 05:01 PM |
| Katkin Keith | Director | Oct 06, 2022 | Option Exercise | $8.20 | 29,899 | 245,177 | 52,782 | Oct 07, 2022, 04:05 PM |
| Katkin Keith | Director | Oct 06, 2022 | Sale | $25.90 | 29,899 | 774,411 | 32,000 | Oct 07, 2022, 04:05 PM |
| Metzger Michael A | Chief Executive Officer | Oct 06, 2022 | Option Exercise | $8.77 | 16,231 | 142,346 | 33,890 | Oct 07, 2022, 04:05 PM |
| Metzger Michael A | Chief Executive Officer | Oct 06, 2022 | Sale | $25.29 | 16,231 | 410,508 | 17,659 | Oct 07, 2022, 04:05 PM |
| Metzger Michael A | Chief Executive Officer | Oct 03, 2022 | Option Exercise | $8.77 | 2,883 | 25,284 | 20,542 | Oct 04, 2022, 05:49 PM |
| Metzger Michael A | Chief Executive Officer | Sep 30, 2022 | Option Exercise | $8.77 | 29,606 | 259,645 | 47,265 | Oct 04, 2022, 05:49 PM |
| Metzger Michael A | Chief Executive Officer | Oct 04, 2022 | Option Exercise | $8.77 | 1,280 | 11,226 | 18,939 | Oct 04, 2022, 05:49 PM |
| Metzger Michael A | Chief Executive Officer | Sep 30, 2022 | Sale | $25.02 | 29,606 | 740,757 | 17,659 | Oct 04, 2022, 05:49 PM |
| Metzger Michael A | Chief Executive Officer | Oct 04, 2022 | Sale | $25.02 | 1,280 | 32,026 | 17,659 | Oct 04, 2022, 05:49 PM |
| Metzger Michael A | Chief Executive Officer | Oct 03, 2022 | Sale | $25.01 | 2,883 | 72,107 | 17,659 | Oct 04, 2022, 05:49 PM |
| Katkin Keith | Director | Oct 03, 2022 | Option Exercise | $7.96 | 180 | 1,432 | 32,167 | Oct 04, 2022, 05:49 PM |
| Katkin Keith | Director | Sep 30, 2022 | Option Exercise | $8.07 | 3,561 | 28,740 | 34,914 | Oct 04, 2022, 05:49 PM |
| Katkin Keith | Director | Oct 04, 2022 | Option Exercise | $8.53 | 360 | 3,071 | 32,223 | Oct 04, 2022, 05:49 PM |
| Katkin Keith | Director | Sep 30, 2022 | Sale | $25.07 | 3,561 | 89,277 | 32,000 | Oct 04, 2022, 05:49 PM |
| Katkin Keith | Director | Oct 04, 2022 | Sale | $25.00 | 360 | 9,000 | 32,000 | Oct 04, 2022, 05:49 PM |
| Katkin Keith | Director | Oct 03, 2022 | Sale | $25.00 | 180 | 4,500 | 32,000 | Oct 04, 2022, 05:49 PM |
| Morrison Briggs | President, Head of R&D | Sep 20, 2022 | Option Exercise | $10.90 | 59,649 | 650,174 | 77,485 | Sep 21, 2022, 04:18 PM |
| Morrison Briggs | President, Head of R&D | Sep 19, 2022 | Option Exercise | $10.90 | 114,339 | 1,246,295 | 132,175 | Sep 21, 2022, 04:18 PM |
| Morrison Briggs | President, Head of R&D | Sep 20, 2022 | Sale | $23.25 | 59,649 | 1,387,012 | 17,836 | Sep 21, 2022, 04:18 PM |
| Morrison Briggs | President, Head of R&D | Sep 19, 2022 | Sale | $23.03 | 114,339 | 2,633,044 | 17,836 | Sep 21, 2022, 04:18 PM |
| Morrison Briggs | President, Head of R&D | Sep 15, 2022 | Option Exercise | $7.20 | 66,775 | 480,780 | 84,611 | Sep 16, 2022, 05:34 PM |
| Morrison Briggs | President, Head of R&D | Sep 14, 2022 | Option Exercise | $7.20 | 87,645 | 631,044 | 105,481 | Sep 16, 2022, 05:34 PM |
| Morrison Briggs | President, Head of R&D | Sep 16, 2022 | Option Exercise | $8.77 | 125,000 | 1,096,226 | 89,802 | Sep 16, 2022, 05:34 PM |
| Morrison Briggs | President, Head of R&D | Sep 15, 2022 | Sale | $24.20 | 66,775 | 1,616,035 | 17,836 | Sep 16, 2022, 05:34 PM |
| Morrison Briggs | President, Head of R&D | Sep 14, 2022 | Sale | $23.80 | 87,645 | 2,085,855 | 17,836 | Sep 16, 2022, 05:34 PM |
| Morrison Briggs | President, Head of R&D | Sep 16, 2022 | Sale | $23.22 | 125,000 | 2,902,437 | 17,836 | Sep 16, 2022, 05:34 PM |
| Podlesak Dennis | Director | Sep 16, 2022 | Option Exercise | $6.34 | 11,975 | 75,879 | 82,319 | Sep 16, 2022, 05:34 PM |
| Podlesak Dennis | Director | Sep 15, 2022 | Option Exercise | $6.32 | 66,840 | 422,429 | 142,603 | Sep 16, 2022, 05:34 PM |
| Podlesak Dennis | Director | Sep 16, 2022 | Sale | $23.43 | 11,975 | 280,607 | 75,763 | Sep 16, 2022, 05:34 PM |
| Podlesak Dennis | Director | Sep 15, 2022 | Sale | $24.20 | 66,840 | 1,617,381 | 75,763 | Sep 16, 2022, 05:34 PM |
| Ordentlich Peter | Chief Scientific Officer | Jul 29, 2022 | Option Exercise | $14.12 | 265 | 3,742 | 265 | Aug 26, 2022, 04:14 PM |
| Ordentlich Peter | Chief Scientific Officer | Aug 24, 2022 | Option Exercise | $6.32 | 25,000 | 158,065 | 23,111 | Aug 26, 2022, 04:14 PM |
| Ordentlich Peter | Chief Scientific Officer | Aug 24, 2022 | Sale | $25.04 | 25,000 | 625,892 | 265 | Aug 26, 2022, 04:14 PM |
| Legault Pierre | Director | Aug 05, 2022 | Option Exercise | $9.22 | 24,000 | 221,320 | 46,000 | Aug 09, 2022, 04:05 PM |
| Legault Pierre | Director | Aug 05, 2022 | Sale | $23.02 | 24,000 | 552,382 | 32,000 | Aug 09, 2022, 04:05 PM |
| Metzger Michael A | Chief Executive Officer | Jul 25, 2022 | Option Exercise | $6.38 | 31,602 | 201,621 | 37,423 | Jul 27, 2022, 06:42 PM |
| Metzger Michael A | Chief Executive Officer | Jul 25, 2022 | Sale | $21.06 | 31,602 | 665,393 | 17,659 | Jul 27, 2022, 06:42 PM |
| Metzger Michael A | Chief Executive Officer | Jul 06, 2022 | Option Exercise | $6.38 | 15,009 | 95,757 | 32,668 | Jul 08, 2022, 05:51 PM |
| Metzger Michael A | Chief Executive Officer | Jul 07, 2022 | Option Exercise | $6.38 | 100 | 638 | 17,759 | Jul 08, 2022, 05:51 PM |
| Metzger Michael A | Chief Executive Officer | Jul 06, 2022 | Sale | $21.07 | 15,009 | 316,307 | 17,659 | Jul 08, 2022, 05:51 PM |
| Metzger Michael A | Chief Executive Officer | Jul 07, 2022 | Sale | $21.00 | 100 | 2,100 | 17,659 | Jul 08, 2022, 05:51 PM |
| Morrison Briggs | President, Head of R&D | Apr 04, 2022 | Option Exercise | $7.20 | 3,128 | 22,522 | 20,964 | Apr 13, 2022, 04:09 PM |
| Morrison Briggs | President, Head of R&D | Apr 01, 2022 | Option Exercise | $7.20 | 70,545 | 507,924 | 88,381 | Apr 13, 2022, 04:09 PM |
| Morrison Briggs | President, Head of R&D | Apr 01, 2022 | Option Exercise | $10.90 | 70,545 | 768,940 | 88,381 | Apr 05, 2022, 04:05 PM |
| Morrison Briggs | President, Head of R&D | Apr 04, 2022 | Option Exercise | $10.90 | 3,128 | 34,095 | 20,964 | Apr 05, 2022, 04:05 PM |
| Morrison Briggs | President, Head of R&D | Apr 01, 2022 | Sale | $17.45 | 101,045 | 1,763,515 | 42,336 | Apr 05, 2022, 04:05 PM |
| Morrison Briggs | President, Head of R&D | Apr 04, 2022 | Sale | $18.29 | 3,128 | 57,220 | 17,836 | Apr 05, 2022, 04:05 PM |
| Ordentlich Peter | Chief Scientific Officer | Jan 31, 2022 | Option Exercise | $12.39 | 1,412 | 17,495 | 1,412 | Feb 03, 2022, 05:32 PM |
| Ordentlich Peter | Chief Scientific Officer | Feb 01, 2022 | Sale | $16.65 | 1,412 | 23,510 | 0 | Feb 03, 2022, 05:32 PM |
| Meyers Michael L. | SVP, Chief Medical Officer | Jan 31, 2022 | Option Exercise | $12.39 | 1,714 | 21,236 | 23,280 | Feb 03, 2022, 05:31 PM |
| Nolte Alexander | Chief Accounting Officer | Jan 31, 2022 | Option Exercise | $12.39 | 968 | 11,994 | 968 | Feb 03, 2022, 05:31 PM |
| Nolte Alexander | Chief Accounting Officer | Feb 01, 2022 | Sale | $16.65 | 968 | 16,117 | 0 | Feb 03, 2022, 05:31 PM |
| Meyers Michael L. | SVP, Chief Medical Officer | Dec 30, 2021 | Option Exercise | $8.77 | 5,900 | 51,743 | 21,566 | Jan 03, 2022, 04:03 PM |
| Legault Pierre | Director | Dec 22, 2021 | Option Exercise | $7.88 | 24,000 | 189,120 | 40,000 | Dec 22, 2021, 06:25 PM |
| Legault Pierre | Director | Dec 20, 2021 | Option Exercise | $7.08 | 20,000 | 141,600 | 36,000 | Dec 22, 2021, 06:25 PM |
| Legault Pierre | Director | Dec 22, 2021 | Sale | $22.01 | 24,000 | 528,206 | 16,000 | Dec 22, 2021, 06:25 PM |
| Legault Pierre | Director | Dec 20, 2021 | Sale | $21.01 | 20,000 | 420,250 | 16,000 | Dec 22, 2021, 06:25 PM |
| Morrison Briggs | Chief Executive Officer | Dec 17, 2021 | Option Exercise | $10.90 | 35,156 | 383,200 | 83,492 | Dec 20, 2021, 06:44 PM |
| Morrison Briggs | Chief Executive Officer | Dec 17, 2021 | Sale | $20.00 | 35,156 | 703,120 | 48,336 | Dec 20, 2021, 06:44 PM |
| Metzger Michael A | President and COO | Dec 20, 2021 | Option Exercise | $8.14 | 61,000 | 496,730 | 62,659 | Dec 20, 2021, 06:44 PM |
| Metzger Michael A | President and COO | Dec 17, 2021 | Option Exercise | $6.38 | 1,676 | 10,693 | 19,335 | Dec 20, 2021, 06:44 PM |
| Metzger Michael A | President and COO | Dec 16, 2021 | Option Exercise | $6.38 | 22,715 | 144,922 | 40,374 | Dec 20, 2021, 06:44 PM |
| Metzger Michael A | President and COO | Dec 17, 2021 | Sale | $19.02 | 1,676 | 31,877 | 17,659 | Dec 20, 2021, 06:44 PM |
| Metzger Michael A | President and COO | Dec 16, 2021 | Sale | $19.08 | 22,715 | 433,400 | 17,659 | Dec 20, 2021, 06:44 PM |
| Metzger Michael A | President and COO | Dec 20, 2021 | Sale | $20.29 | 61,000 | 1,237,568 | 17,659 | Dec 20, 2021, 06:44 PM |
| Metzger Michael A | President and COO | Dec 13, 2021 | Option Exercise | $6.43 | 36,609 | 235,242 | 52,223 | Dec 15, 2021, 05:35 PM |
| Metzger Michael A | President and COO | Dec 13, 2021 | Sale | $19.05 | 36,609 | 697,519 | 17,659 | Dec 15, 2021, 05:35 PM |
| Egros Fabrice | Director | Nov 18, 2021 | Option Exercise | $8.93 | 14,030 | 125,256 | 30,000 | Nov 19, 2021, 04:06 PM |
| Egros Fabrice | Director | Nov 18, 2021 | Sale | $18.03 | 14,030 | 252,993 | 16,000 | Nov 19, 2021, 04:06 PM |
| Metzger Michael A | President and COO | Oct 26, 2021 | Option Exercise | $7.20 | 16,296 | 117,331 | 33,955 | Oct 27, 2021, 04:11 PM |
| Metzger Michael A | President and COO | Oct 25, 2021 | Option Exercise | $7.20 | 44,704 | 321,869 | 62,363 | Oct 27, 2021, 04:11 PM |
| Metzger Michael A | President and COO | Oct 25, 2021 | Sale | $19.13 | 44,704 | 855,335 | 17,659 | Oct 27, 2021, 04:11 PM |
| Metzger Michael A | President and COO | Oct 26, 2021 | Sale | $19.20 | 16,296 | 312,825 | 17,659 | Oct 27, 2021, 04:11 PM |
| Metzger Michael A | President and COO | Sep 27, 2021 | Option Exercise | $7.20 | 24,437 | 175,946 | 42,096 | Sep 28, 2021, 04:36 PM |
| Metzger Michael A | President and COO | Sep 27, 2021 | Sale | $19.51 | 24,437 | 476,832 | 17,659 | Sep 28, 2021, 04:36 PM |
| Metzger Michael A | President and COO | Sep 22, 2021 | Option Exercise | $7.20 | 300 | 2,160 | 17,959 | Sep 22, 2021, 04:50 PM |
| Metzger Michael A | President and COO | Sep 21, 2021 | Option Exercise | $7.20 | 4,808 | 34,618 | 22,467 | Sep 22, 2021, 04:50 PM |
| Metzger Michael A | President and COO | Sep 20, 2021 | Option Exercise | $7.20 | 31,455 | 226,476 | 49,114 | Sep 22, 2021, 04:50 PM |
| Metzger Michael A | President and COO | Sep 21, 2021 | Sale | $19.16 | 4,808 | 92,108 | 17,659 | Sep 22, 2021, 04:50 PM |
| Metzger Michael A | President and COO | Sep 20, 2021 | Sale | $19.24 | 31,455 | 605,046 | 17,659 | Sep 22, 2021, 04:50 PM |
| Metzger Michael A | President and COO | Sep 22, 2021 | Sale | $19.02 | 300 | 5,706 | 17,659 | Sep 22, 2021, 04:50 PM |
| Morrison Briggs | Chief Executive Officer | Sep 20, 2021 | Option Exercise | $7.20 | 50 | 360 | 48,386 | Sep 21, 2021, 04:35 PM |
| Morrison Briggs | Chief Executive Officer | Sep 17, 2021 | Option Exercise | $7.20 | 70,262 | 505,886 | 118,598 | Sep 21, 2021, 04:35 PM |
| Morrison Briggs | Chief Executive Officer | Sep 17, 2021 | Sale | $20.07 | 70,262 | 1,410,018 | 48,336 | Sep 21, 2021, 04:35 PM |
| Morrison Briggs | Chief Executive Officer | Sep 20, 2021 | Sale | $20.00 | 50 | 1,000 | 48,336 | Sep 21, 2021, 04:35 PM |
| Metzger Michael A | President and COO | Sep 14, 2021 | Option Exercise | $7.20 | 44,349 | 319,313 | 62,008 | Sep 15, 2021, 04:16 PM |
| Metzger Michael A | President and COO | Sep 13, 2021 | Option Exercise | $7.20 | 16,651 | 119,887 | 34,310 | Sep 15, 2021, 04:16 PM |
| Metzger Michael A | President and COO | Sep 14, 2021 | Sale | $19.15 | 44,349 | 849,394 | 17,659 | Sep 15, 2021, 04:16 PM |
| Metzger Michael A | President and COO | Sep 13, 2021 | Sale | $19.02 | 16,651 | 316,639 | 17,659 | Sep 15, 2021, 04:16 PM |
| Egros Fabrice | Director | Aug 18, 2021 | Option Exercise | $7.88 | 15,635 | 123,204 | 31,635 | Aug 20, 2021, 04:32 PM |
| Egros Fabrice | Director | Aug 18, 2021 | Sale | $15.75 | 15,635 | 246,328 | 16,000 | Aug 20, 2021, 04:32 PM |
| Egros Fabrice | Director | May 18, 2021 | Option Exercise | $7.28 | 13,609 | 99,129 | 29,609 | May 20, 2021, 04:46 PM |
| Egros Fabrice | Director | May 18, 2021 | Sale | $18.65 | 13,609 | 253,783 | 17,683 | May 20, 2021, 04:46 PM |
| Meyers Michael L. | SVP, Chief Medical Officer | Apr 26, 2021 | Buy | $15.46 | 500 | 7,730 | 15,666 | Apr 28, 2021, 04:15 PM |
| Podlesak Dennis | Director | Apr 22, 2021 | Buy | $14.11 | 13,967 | 197,077 | 43,300 | Apr 22, 2021, 05:06 PM |
| Egros Fabrice | Director | Mar 01, 2021 | Option Exercise | $6.36 | 10,241 | 65,093 | 26,241 | Mar 03, 2021, 04:16 PM |
| Egros Fabrice | Director | Mar 01, 2021 | Sale | $24.31 | 10,241 | 248,981 | 16,074 | Mar 03, 2021, 04:16 PM |
| Morrison Briggs | Chief Executive Officer | Feb 08, 2021 | Option Exercise | $7.20 | 35,156 | 253,123 | 83,492 | Feb 10, 2021, 04:23 PM |
| Morrison Briggs | Chief Executive Officer | Feb 08, 2021 | Sale | $20.55 | 35,156 | 722,403 | 48,336 | Feb 10, 2021, 04:23 PM |
| Morrison Briggs | Chief Executive Officer | Jan 31, 2021 | Option Exercise | $12.00 | 1,771 | 21,252 | 48,336 | Feb 05, 2021, 04:21 PM |
| Meyers Michael L. | SVP, Chief Medical Officer | Jan 31, 2021 | Option Exercise | $12.00 | 1,771 | 21,252 | 15,166 | Feb 05, 2021, 04:21 PM |
| Meyers Michael L. | SVP, Chief Medical Officer | Jul 31, 2020 | Option Exercise | $7.97 | 2,665 | 21,240 | 13,395 | Feb 05, 2021, 04:21 PM |
| Metzger Michael A | President and COO | Feb 01, 2021 | Option Exercise | $7.20 | 15,000 | 108,000 | 32,659 | Feb 03, 2021, 05:53 PM |
| Metzger Michael A | President and COO | Feb 01, 2021 | Sale | $20.19 | 15,000 | 302,799 | 17,659 | Feb 03, 2021, 05:53 PM |
| Metzger Michael A | President and COO | Dec 01, 2020 | Option Exercise | $7.20 | 15,000 | 108,000 | 32,659 | Dec 03, 2020, 06:05 PM |
| Metzger Michael A | President and COO | Dec 01, 2020 | Sale | $22.97 | 15,000 | 344,513 | 17,659 | Dec 03, 2020, 06:05 PM |
| Ordentlich Peter | Chief Scientific Officer | Nov 23, 2020 | Option Exercise | $3.08 | 29,972 | 92,314 | 29,972 | Nov 25, 2020, 04:38 PM |
| Ordentlich Peter | Chief Scientific Officer | Nov 23, 2020 | Sale | $23.16 | 29,972 | 694,121 | 24,288 | Nov 25, 2020, 04:38 PM |
| Morrison Briggs | Chief Executive Officer | Nov 10, 2020 | Option Exercise | $7.20 | 17,466 | 125,755 | 64,031 | Nov 12, 2020, 05:55 PM |
| Morrison Briggs | Chief Executive Officer | Nov 09, 2020 | Option Exercise | $7.20 | 62,938 | 453,154 | 109,503 | Nov 12, 2020, 05:55 PM |
| Morrison Briggs | Chief Executive Officer | Nov 10, 2020 | Sale | $20.06 | 17,466 | 350,312 | 46,565 | Nov 12, 2020, 05:55 PM |
| Morrison Briggs | Chief Executive Officer | Nov 09, 2020 | Sale | $20.04 | 62,938 | 1,261,265 | 46,565 | Nov 12, 2020, 05:55 PM |
| Metzger Michael A | President and COO | Nov 04, 2020 | Option Exercise | $7.20 | 100,000 | 720,000 | 117,659 | Nov 06, 2020, 05:55 PM |
| Metzger Michael A | President and COO | Nov 04, 2020 | Sale | $20.31 | 100,000 | 2,031,410 | 17,659 | Nov 06, 2020, 05:55 PM |
| Shea Richard P | Chief Financial Officer | Jan 31, 2020 | Option Exercise | $7.97 | 1,505 | 11,995 | 7,121 | Feb 14, 2020, 04:37 PM |
| Shea Richard P | Chief Financial Officer | Jul 31, 2019 | Option Exercise | $4.89 | 1,401 | 6,851 | 5,616 | Feb 14, 2020, 04:37 PM |
| Morrison Briggs | Chief Executive Officer | Feb 04, 2020 | Buy | $8.00 | 12,500 | 100,000 | 43,900 | Feb 05, 2020, 04:07 PM |
| Morrison Briggs | Chief Executive Officer | Oct 10, 2019 | Buy | $5.40 | 11,000 | 59,400 | 31,400 | Oct 11, 2019, 06:33 AM |
| Morrison Briggs | Chief Executive Officer | May 13, 2019 | Buy | $7.29 | 7,200 | 52,517 | 20,400 | May 13, 2019, 04:11 PM |
| Morrison Briggs | Chief Executive Officer | May 09, 2019 | Buy | $7.55 | 13,200 | 99,726 | 13,200 | May 13, 2019, 04:11 PM |
| Meyers Michael L. | SVP, Chief Medical Officer | Mar 21, 2019 | Buy | $4.87 | 8 | 39 | 7,230 | Mar 25, 2019, 04:03 PM |
| Meyers Michael L. | SVP, Chief Medical Officer | Mar 21, 2019 | Buy | $4.92 | 1,104 | 5,436 | 7,222 | Mar 22, 2019, 04:05 PM |
| Shea Richard P | Chief Financial Officer | Jan 31, 2019 | Option Exercise | $4.76 | 2,521 | 12,000 | 4,215 | Feb 08, 2019, 04:27 PM |
| Meyers Michael L. | SVP, Chief Medical Officer | Jan 31, 2019 | Option Exercise | $4.76 | 3,720 | 17,707 | 6,118 | Feb 08, 2019, 04:27 PM |
| Metzger Michael A | President and COO | Jan 31, 2019 | Option Exercise | $4.76 | 2,659 | 12,657 | 2,659 | Feb 08, 2019, 04:27 PM |
| Meyers Michael L. | SVP, Chief Medical Officer | Oct 30, 2018 | Buy | $4.79 | 200 | 958 | 2,398 | Nov 07, 2018, 04:02 PM |
| Ordentlich Peter | Chief Scientific Officer | Apr 03, 2018 | Option Exercise | $3.08 | 7,500 | 23,100 | 7,500 | Apr 03, 2018, 04:42 PM |
| Ordentlich Peter | Chief Scientific Officer | Apr 03, 2018 | Sale | $15.00 | 7,500 | 112,500 | 0 | Apr 03, 2018, 04:42 PM |
| Ordentlich Peter | Chief Scientific Officer | May 17, 2017 | Option Exercise | $3.08 | 732 | 2,255 | 5,000 | May 19, 2017, 11:27 AM |
| Ordentlich Peter | Chief Scientific Officer | May 17, 2017 | Sale | $15.00 | 5,000 | 75,000 | 0 | May 19, 2017, 11:27 AM |
| ROYSTON IVOR | Director | Mar 20, 2017 | Option Exercise | $13.75 | 125,000 | 1,718,750 | 625,545 | Mar 22, 2017, 01:37 PM |
| ROYSTON IVOR | Director | Mar 08, 2016 | Buy | $12.00 | 150,000 | 1,800,000 | 750,545 | Mar 08, 2016, 06:38 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Goldan Keith A. | Chief Financial Officer | 06/14/2024 | 25,037 |
| Goldan Keith A. | Chief Financial Officer | 01/31/2024 | 20,608 |
| Goldan Keith A. | Chief Financial Officer | 07/31/2023 | 15,619 |
| Morrison Briggs | Director | 08/09/2023 | 463,538 |
| Morrison Briggs | Director | 08/09/2023 | 965,402 |
| Meury William | Director | 08/02/2023 | 665,250 |
| Meury William | Director | 08/02/2023 | 1,697,810 |
| Morrison Briggs | Director | 07/10/2023 | 463,538 |
| Morrison Briggs | Director | 07/10/2023 | 1,078,068 |
| Goldan Keith A. | Chief Financial Officer | 06/13/2023 | 12,873 |
| Morrison Briggs | Director | 06/09/2023 | 404,787 |
| Morrison Briggs | Director | 06/09/2023 | 1,119,421 |
| Morrison Briggs | Director | 05/09/2023 | 337,215 |
| Morrison Briggs | Director | 05/09/2023 | 1,131,478 |
| Morrison Briggs | Director | 04/10/2023 | 337,215 |
| Morrison Briggs | Director | 04/10/2023 | 1,032,237 |
| Morrison Briggs | President, Head of R&D | 03/13/2023 | 337,209 |
| Morrison Briggs | President, Head of R&D | 03/13/2023 | 1,190,674 |
| Ordentlich Peter | Chief Scientific Officer | 02/15/2023 | 173,791 |
| Ordentlich Peter | Chief Scientific Officer | 02/15/2023 | 646,093 |
| Metzger Michael A | Chief Executive Officer | 02/06/2023 | 38,018 |
| Metzger Michael A | Chief Executive Officer | 02/06/2023 | 164,697 |
| Morrison Briggs | President, Head of R&D | 02/06/2023 | 337,209 |
| Morrison Briggs | President, Head of R&D | 02/06/2023 | 1,417,909 |
| Ordentlich Peter | Chief Scientific Officer | 01/31/2023 | 1,195 |
| Ordentlich Peter | Chief Scientific Officer | 02/01/2023 | 1,962 |
| Legault Pierre | Director | 01/12/2023 | 227,280 |
| Legault Pierre | Director | 01/13/2023 | 203,700 |
| Legault Pierre | Director | 01/12/2023 | 641,782 |
| Legault Pierre | Director | 01/13/2023 | 405,000 |
| Ordentlich Peter | Chief Scientific Officer | 12/02/2022 | 109,736 |
| Ordentlich Peter | Chief Scientific Officer | 12/01/2022 | 49,651 |
| Ordentlich Peter | Chief Scientific Officer | 12/02/2022 | 430,936 |
| Ordentlich Peter | Chief Scientific Officer | 12/01/2022 | 195,089 |
| Katkin Keith | Director | 10/06/2022 | 245,177 |
| Katkin Keith | Director | 10/06/2022 | 774,411 |
| Metzger Michael A | Chief Executive Officer | 10/06/2022 | 142,346 |
| Metzger Michael A | Chief Executive Officer | 10/06/2022 | 410,508 |
| Metzger Michael A | Chief Executive Officer | 10/03/2022 | 25,284 |
| Metzger Michael A | Chief Executive Officer | 09/30/2022 | 259,645 |
| Metzger Michael A | Chief Executive Officer | 10/04/2022 | 11,226 |
| Metzger Michael A | Chief Executive Officer | 09/30/2022 | 740,757 |
| Metzger Michael A | Chief Executive Officer | 10/04/2022 | 32,026 |
| Metzger Michael A | Chief Executive Officer | 10/03/2022 | 72,107 |
| Katkin Keith | Director | 10/03/2022 | 1,432 |
| Katkin Keith | Director | 09/30/2022 | 28,740 |
| Katkin Keith | Director | 10/04/2022 | 3,071 |
| Katkin Keith | Director | 09/30/2022 | 89,277 |
| Katkin Keith | Director | 10/04/2022 | 9,000 |
| Katkin Keith | Director | 10/03/2022 | 4,500 |
| Morrison Briggs | President, Head of R&D | 09/20/2022 | 650,174 |
| Morrison Briggs | President, Head of R&D | 09/19/2022 | 1,246,295 |
| Morrison Briggs | President, Head of R&D | 09/20/2022 | 1,387,012 |
| Morrison Briggs | President, Head of R&D | 09/19/2022 | 2,633,044 |
| Morrison Briggs | President, Head of R&D | 09/15/2022 | 480,780 |
| Morrison Briggs | President, Head of R&D | 09/14/2022 | 631,044 |
| Morrison Briggs | President, Head of R&D | 09/16/2022 | 1,096,226 |
| Morrison Briggs | President, Head of R&D | 09/15/2022 | 1,616,035 |
| Morrison Briggs | President, Head of R&D | 09/14/2022 | 2,085,855 |
| Morrison Briggs | President, Head of R&D | 09/16/2022 | 2,902,437 |
| Podlesak Dennis | Director | 09/16/2022 | 75,879 |
| Podlesak Dennis | Director | 09/15/2022 | 422,429 |
| Podlesak Dennis | Director | 09/16/2022 | 280,607 |
| Podlesak Dennis | Director | 09/15/2022 | 1,617,381 |
| Ordentlich Peter | Chief Scientific Officer | 07/29/2022 | 3,742 |
| Ordentlich Peter | Chief Scientific Officer | 08/24/2022 | 158,065 |
| Ordentlich Peter | Chief Scientific Officer | 08/24/2022 | 625,892 |
| Legault Pierre | Director | 08/05/2022 | 221,320 |
| Legault Pierre | Director | 08/05/2022 | 552,382 |
| Metzger Michael A | Chief Executive Officer | 07/25/2022 | 201,621 |
| Metzger Michael A | Chief Executive Officer | 07/25/2022 | 665,393 |
| Metzger Michael A | Chief Executive Officer | 07/06/2022 | 95,757 |
| Metzger Michael A | Chief Executive Officer | 07/07/2022 | 638 |
| Metzger Michael A | Chief Executive Officer | 07/06/2022 | 316,307 |
| Metzger Michael A | Chief Executive Officer | 07/07/2022 | 2,100 |
| Morrison Briggs | President, Head of R&D | 04/04/2022 | 22,522 |
| Morrison Briggs | President, Head of R&D | 04/01/2022 | 507,924 |
| Morrison Briggs | President, Head of R&D | 04/01/2022 | 768,940 |
| Morrison Briggs | President, Head of R&D | 04/04/2022 | 34,095 |
| Morrison Briggs | President, Head of R&D | 04/01/2022 | 1,763,515 |
| Morrison Briggs | President, Head of R&D | 04/04/2022 | 57,220 |
| Ordentlich Peter | Chief Scientific Officer | 01/31/2022 | 17,495 |
| Ordentlich Peter | Chief Scientific Officer | 02/01/2022 | 23,510 |
| Meyers Michael L. | SVP, Chief Medical Officer | 01/31/2022 | 21,236 |
| Nolte Alexander | Chief Accounting Officer | 01/31/2022 | 11,994 |
| Nolte Alexander | Chief Accounting Officer | 02/01/2022 | 16,117 |
| Meyers Michael L. | SVP, Chief Medical Officer | 12/30/2021 | 51,743 |
| Legault Pierre | Director | 12/22/2021 | 189,120 |
| Legault Pierre | Director | 12/20/2021 | 141,600 |
| Legault Pierre | Director | 12/22/2021 | 528,206 |
| Legault Pierre | Director | 12/20/2021 | 420,250 |
| Morrison Briggs | Chief Executive Officer | 12/17/2021 | 383,200 |
| Morrison Briggs | Chief Executive Officer | 12/17/2021 | 703,120 |
| Metzger Michael A | President and COO | 12/20/2021 | 496,730 |
| Metzger Michael A | President and COO | 12/17/2021 | 10,693 |
| Metzger Michael A | President and COO | 12/16/2021 | 144,922 |
| Metzger Michael A | President and COO | 12/17/2021 | 31,877 |
| Metzger Michael A | President and COO | 12/16/2021 | 433,400 |
| Metzger Michael A | President and COO | 12/20/2021 | 1,237,568 |
| Metzger Michael A | President and COO | 12/13/2021 | 235,242 |
| Metzger Michael A | President and COO | 12/13/2021 | 697,519 |
| Egros Fabrice | Director | 11/18/2021 | 125,256 |
| Egros Fabrice | Director | 11/18/2021 | 252,993 |
| Metzger Michael A | President and COO | 10/26/2021 | 117,331 |
| Metzger Michael A | President and COO | 10/25/2021 | 321,869 |
| Metzger Michael A | President and COO | 10/25/2021 | 855,335 |
| Metzger Michael A | President and COO | 10/26/2021 | 312,825 |
| Metzger Michael A | President and COO | 09/27/2021 | 175,946 |
| Metzger Michael A | President and COO | 09/27/2021 | 476,832 |
| Metzger Michael A | President and COO | 09/22/2021 | 2,160 |
| Metzger Michael A | President and COO | 09/21/2021 | 34,618 |
| Metzger Michael A | President and COO | 09/20/2021 | 226,476 |
| Metzger Michael A | President and COO | 09/21/2021 | 92,108 |
| Metzger Michael A | President and COO | 09/20/2021 | 605,046 |
| Metzger Michael A | President and COO | 09/22/2021 | 5,706 |
| Morrison Briggs | Chief Executive Officer | 09/20/2021 | 360 |
| Morrison Briggs | Chief Executive Officer | 09/17/2021 | 505,886 |
| Morrison Briggs | Chief Executive Officer | 09/17/2021 | 1,410,018 |
| Morrison Briggs | Chief Executive Officer | 09/20/2021 | 1,000 |
| Metzger Michael A | President and COO | 09/14/2021 | 319,313 |
| Metzger Michael A | President and COO | 09/13/2021 | 119,887 |
| Metzger Michael A | President and COO | 09/14/2021 | 849,394 |
| Metzger Michael A | President and COO | 09/13/2021 | 316,639 |
| Egros Fabrice | Director | 08/18/2021 | 123,204 |
| Egros Fabrice | Director | 08/18/2021 | 246,328 |
| Egros Fabrice | Director | 05/18/2021 | 99,129 |
| Egros Fabrice | Director | 05/18/2021 | 253,783 |
| Meyers Michael L. | SVP, Chief Medical Officer | 04/26/2021 | 7,730 |
| Podlesak Dennis | Director | 04/22/2021 | 197,077 |
| Egros Fabrice | Director | 03/01/2021 | 65,093 |
| Egros Fabrice | Director | 03/01/2021 | 248,981 |
| Morrison Briggs | Chief Executive Officer | 02/08/2021 | 253,123 |
| Morrison Briggs | Chief Executive Officer | 02/08/2021 | 722,403 |
| Morrison Briggs | Chief Executive Officer | 01/31/2021 | 21,252 |
| Meyers Michael L. | SVP, Chief Medical Officer | 01/31/2021 | 21,252 |
| Meyers Michael L. | SVP, Chief Medical Officer | 07/31/2020 | 21,240 |
| Metzger Michael A | President and COO | 02/01/2021 | 108,000 |
| Metzger Michael A | President and COO | 02/01/2021 | 302,799 |
| Metzger Michael A | President and COO | 12/01/2020 | 108,000 |
| Metzger Michael A | President and COO | 12/01/2020 | 344,513 |
| Ordentlich Peter | Chief Scientific Officer | 11/23/2020 | 92,314 |
| Ordentlich Peter | Chief Scientific Officer | 11/23/2020 | 694,121 |
| Morrison Briggs | Chief Executive Officer | 11/10/2020 | 125,755 |
| Morrison Briggs | Chief Executive Officer | 11/09/2020 | 453,154 |
| Morrison Briggs | Chief Executive Officer | 11/10/2020 | 350,312 |
| Morrison Briggs | Chief Executive Officer | 11/09/2020 | 1,261,265 |
| Metzger Michael A | President and COO | 11/04/2020 | 720,000 |
| Metzger Michael A | President and COO | 11/04/2020 | 2,031,410 |
| Shea Richard P | Chief Financial Officer | 01/31/2020 | 11,995 |
| Shea Richard P | Chief Financial Officer | 07/31/2019 | 6,851 |
| Morrison Briggs | Chief Executive Officer | 02/04/2020 | 100,000 |
| Morrison Briggs | Chief Executive Officer | 10/10/2019 | 59,400 |
| Morrison Briggs | Chief Executive Officer | 05/13/2019 | 52,517 |
| Morrison Briggs | Chief Executive Officer | 05/09/2019 | 99,726 |
| Meyers Michael L. | SVP, Chief Medical Officer | 03/21/2019 | 39 |
| Meyers Michael L. | SVP, Chief Medical Officer | 03/21/2019 | 5,436 |
| Shea Richard P | Chief Financial Officer | 01/31/2019 | 12,000 |
| Meyers Michael L. | SVP, Chief Medical Officer | 01/31/2019 | 17,707 |
| Metzger Michael A | President and COO | 01/31/2019 | 12,657 |
| Meyers Michael L. | SVP, Chief Medical Officer | 10/30/2018 | 958 |
| Ordentlich Peter | Chief Scientific Officer | 04/03/2018 | 23,100 |
| Ordentlich Peter | Chief Scientific Officer | 04/03/2018 | 112,500 |
| Ordentlich Peter | Chief Scientific Officer | 05/17/2017 | 2,255 |
| Ordentlich Peter | Chief Scientific Officer | 05/17/2017 | 75,000 |
| ROYSTON IVOR | Director | 03/20/2017 | 1,718,750 |
| ROYSTON IVOR | Director | 03/08/2016 | 1,800,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN SYNDAX PHARMACEUTICALS, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 7,906,765 | 0.00367% | 4.69% | Other |
| ORBIMED ADVISORS LLC | 1,925,300 | 0.78% | 10.08% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,910,623 | 0.00344% | 7.43% | Other |
| CANDRIAM S.C.A. | 970,106 | 0.12% | -7.17% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 860,000 | 0.03% | -4.44% | Other |
| PALO ALTO INVESTORS LP | 405,193 | 0.96% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 214,300 | 0.00746% | 170.92% | Other |
| D. E. SHAW & CO., INC. | 146,643 | 0.00282% | 1620.35% | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 110,454 | 0.14% | 1.87% | Value |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 77,400 (Call) | 0.00321% | Exited | Value |
| ALPS ADVISORS INC | 66,293 | 0.00934% | 10.63% | Other |
| AQR CAPITAL MANAGEMENT LLC | 27,273 | 0.00086% | -48.75% | Other |
| TUDOR INVESTMENT CORP ET AL | 47,153 | 0.00496% | New | Event Driven, Other |
| FARALLON CAPITAL MANAGEMENT LLC | 10,000 | 0.00097% | No change | Event Driven, Value |
CHANGE IN SHARES OUTSTANDING FOR SYNDAX PHARMACEUTICALS, INC.
STOCK BUYBACKS FOR SYNDAX PHARMACEUTICALS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
17.46%
1Q
09/30/2023
21.98%
2Q
06/30/2023
22.37%
3Q
03/31/2023
22.72%
4Q
12/31/2022
34.79%
5Q
09/30/2022
40.45%
6Q
06/30/2022
41.65%
7Q
03/31/2022
44.48%
8Q
12/31/2021
43.41%
9Q
09/30/2021
63.99%
10Q
06/30/2021
65.13%
11Q
03/31/2021
65.46%
12Q
12/31/2020
84.89%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SYNDAX PHARMACEUTICALS, INC.
LOADING...